Autoimmune Hemolytic Anemia

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2017 English Publisher:Elsevier BVJournal:Medical Clinics of North America, volume 101, pages 351-359 (issn: 0025-7125,

Copyright policy )

Authors: Howard A, Liebman; Ilene C, Weitz;

doi: 10.1016/j.mcna.2016.09.007

pmid: 28189175

Autoimmune Hemolytic Anemia

- Summary
- Subjects
- Metrics

Abstract

Autoimmune hemolytic anemia is an acquired autoimmune disorder resulting in the production of antibodies directed against red blood cell antigens causing shortened erythrocyte survival. The disorders can present as a primary disorder (idiopathic) or secondary to other autoimmune disorders, malignancies, or infections. Treatment involves immune modulation with corticosteroids and other agents.

Related Organizations

University of California System
United States
UNIVERSITY OF SOUTHERN CALIFORNIA
United States

Keywords

Hematologic Tests, Splenectomy, Humans, Anemia, Hemolytic, Autoimmune, Immunosuppressive Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	67
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%